Anti-TNF treatment response in rheumatoid arthritis patients is associated with genetic variation in the NLRP3-inflammasome

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Sode, Jacob ^a,b,c   Vogel, Ulla ^d   Bank, Steffen ^e,f   Andersen, Paal Skytt ^a   Thomsen, Marianne Kragh ^g   Hetland, Merete Lund ^h,i   Locht, Henning ^b   Heegaard, Niels H H ^a   Andersen, Vibeke ^c,e,j,k  

^a STATENS SERUM INSTITUT   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^e VIBORG HOSPITAL   (Denmark)

^f AARHUS UNIVERSITY   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j Hospital of Southern Jutland   (Denmark)

^k ODENSE UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; CRYOPYRIN; ETANERCEPT; GAMMA INTERFERON; GOLIMUMAB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INFLIXIMAB; PATTERN RECOGNITION RECEPTOR; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; CARRIER PROTEIN; NLRP3 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ACR50 RESPONSE; ADULT; ARTICLE; DAS28; DENMARK; EULAR RESPONSE; FEMALE; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; INTERFERON GAMMA GENE; MAJOR CLINICAL STUDY; MALE; NLRP3 GENE; PHARMACOGENETICS; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TNFRSF1A GENE; ARTHRITIS, RHEUMATOID; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; MOLECULARLY TARGETED THERAPY; PATHOLOGY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CARRIER PROTEINS; FEMALE; HUMANS; INFLAMMASOMES; MALE; MIDDLE AGED; MOLECULAR TARGETED THERAPY; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION; SMOKING; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903391810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100361     Document Type: Article

References (36)

1. Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, et al. (2010) Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis Rheum 62: 22-32. 10.1002/art.27227 [doi].
2. Rosenblum H, Amital H (2011) Anti-TNF therapy: safety aspects of taking the risk. Autoimmun Rev 10: 563-568. 10.1016/j.autrev.2011.04.010 [doi].
3. Emery P, Dorner T (2011) Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response. Ann Rheum Dis 70: 2063-2070. 10.1136/ard.2010.148015 [doi].
4. Toonen EJ, Gilissen C, Franke B, Kievit W, Eijsbouts AM, et al. (2012) Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis. PLoS One 7: e33199. 10.1371/journal.pone. 0033199 [doi];PONE-D-11-21951 [pii].
5. Cui J, Saevarsdottir S, Thomson B, Padyukov L, van der Helm-van Mil AH, et al. (2010) Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy. Arthritis Rheum 62: 1849-1861. 10.1002/art.27457 [doi].
6. Plant D, Prajapati R, Hyrich KL, Morgan AW, Wilson AG, et al. (2012) Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort. Arthritis Rheum 64: 665-670. 10.1002/art.33381 [doi].
7. Krintel SB, Palermo G, Johansen JS, Germer S, Essioux L, et al. (2012) Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFalpha inhibitors in patients with rheumatoid arthritis. Pharmacogenet Genomics 22: 577-589. 10.1097/FPC.0b013e3283544043 [doi].
8. Umicevic MM, Cui J, Vermeulen SH, Stahl EA, Toonen EJ, et al. (2012) Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis. Ann Rheum Dis 0: 1-7. annrheumdis-2012-202405 [pii];10.1136/annrheumdis-2012-202405 [doi].
9. Mathews RJ, Robinson JI, Battellino M, Wong C, Taylor JC, et al. (2013) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis 0: 1-9. annrheumdis-2013-203276 [pii];10.1136/annrheumdis-2013-203276 [doi].
10. Potter C, Cordell HJ, Barton A, Daly AK, Hyrich KL, et al. (2010) Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways. Ann Rheum Dis 69: 1315-1320. ard.2009.117309 [pii];10.1136/ard.2009.117309 [doi].
11. Strowig T, Henao-Mejia J, Elinav E, Flavell R (2012) Inflammasomes in health and disease. Nature 481: 278-286. 10.1038/nature10759 [doi].
12. van LG, Beyaert R (2011) Negative regulation of NF-kappaB and its involvement in rheumatoid arthritis. Arthritis Res Ther 13: 221. ar3324 [pii];10.1186/ar3324 [doi].
13. Goh FG, Midwood KS (2012) Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 51: 7-23. ker257 [pii];10.1093/rheumatology/ker257 [doi].
14. Rosengren S, Hoffman HM, Bugbee W, Boyle DL (2005) Expression and regulation of cryopyrin and related proteins in rheumatoid arthritis synovium. Ann Rheum Dis 64: 708-714. ard.2004.025577 [pii];10.1136/ard.2004.025577 [doi].
15. Klareskog L, Catrina AI, Paget S (2009) Rheumatoid arthritis. Lancet 373: 659-672. S0140-6736(09)60008-8 [pii];10.1016/S0140-6736(09)60008-8 [doi].
16. Hetland ML (2011) DANBIO-powerful research database and electronic patient record. Rheumatology (Oxford) 50: 69-77. keq309 [pii];10.1093/ rheumatology/keq309 [doi].
17. Bank S, Andersen PS, Burisch J, Pedersen N, Roug S, et al. (2014) Associations between functional polymorphisms in the NFkappaB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease. Pharmacogenomics J. tpj201419 [pii];10.1038/tpj.2014.19 [doi].
18. Bank S, Andersen PS, Nexo BA, Sode J, Vogel U, et al. (2014) Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort. PLoS ONE (Accepted for publication).
19. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938-2939. btn564 [pii];10.1093/bioinformatics/ btn564 [doi].
20. Bank S, Nexo BA, Andersen V, Vogel U, Andersen PS (2013) High-Quality and -Quantity DNA Extraction from Frozen Archival Blood Clots for Genotyping of Single-Nucleotide Polymorphisms. Genet Test Mol Biomarkers 17: 501-503. 10.1089/gtmb.2012.0429 [doi].
21. Fransen J, van Riel PL (2005) The Disease Activity Score and the EULAR response criteria. Clin Exp Rheumatol 23: S93-S99. (Pubitemid 46657516)
22. Purcell S, Cherny SS, Sham PC (2003) Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19: 149-150. (Pubitemid 36150192)
23. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 57: 289-300.
24. Blomgran R, Patcha BV, Verma D, Bergstrom I, Soderkvist P, et al. (2012) Common genetic variations in the NALP3 inflammasome are associated with delayed apoptosis of human neutrophils. PLoS One 7: e31326. 10.1371/journal.pone.0031326 [doi];PONE-D-10-02541 [pii].
25. Hitomi Y, Ebisawa M, Tomikawa M, Imai T, Komata T, et al. (2009) Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. J Allergy Clin Immunol 124: 779-785.
26. Valavanidis A, Vlachogianni T, Fiotakis K (2009) Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health 6: 445-462. 10.3390/ijerph6020445 [doi].
27. Simard JC, Cesaro A, Chapeton-Montes J, Tardif M, Antoine F, et al. (2013) S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-kB. PLoS ONE 8: e72138. doi:10.1371/journal.pone.0072138.
28. Perneger TV (1998) What's wrong with Bonferroni adjustments. BMJ 316: 1236-1238.
29. Plenge RM, Bridges SL, Huizinga TWJ, Criswell LA, Gregersen PK (2011) Recommendations for publication of genetic association studies in Arthritis & Rheumatism. Arthritis & Rheumatism 63: 2839-2847.
30. Hetland ML, Lindegaard HM, Hansen A, Podenphant J, Unkerskov J, et al. (2008) Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry. Ann Rheum Dis 67: 1023-1026. ard.2007.087262 [pii];10.1136/ard.2007.087262 [doi].
31. Coenen MJ, Enevold C, Barrera P, Schijvenaars MM, Toonen EJ, et al. (2010) Genetic variants in toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. PLoS One 5: e14326. 10.1371/journal.pone.0014326 [doi].
32. Wang GB, Li CR, Yang J, Wen PQ, Jia SL (2011) A regulatory polymorphism in promoter region of TNFR1 gene is associated with Kawasaki disease in Chinese individuals. Hum Immunol 72: 451-457. S0198-8859(11)00032-2 [pii];10.1016/j. humimm.2011.02.004 [doi].
33. Espinoza JL, Takami A, Nakata K, Onizuka M, Kawase T, et al. (2011) A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One 6: e26229. 10.1371/journal.pone.0026229 [doi];PONE-D-11-15752 [pii].
34. Chen H, Wilkins LM, Aziz N, Cannings C, Wyllie DH, et al. (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15: 519-529. ddi469 [pii];10.1093/hmg/ddi469 [doi].
35. Gu W, Shan YA, Zhou J, Jiang DP, Zhang L, et al. (2007) Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2. Ann Surg 246: 151-158. 10.1097/01.sla.0000262788.67171.3f [doi];00000658- 200707000-00023 [pii].
36. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Human Immunology 61: 863-866. 10.1016/S0198-8859(00)00167- 1 [doi].